1. Home
  2. TCBS vs DRIO Comparison

TCBS vs DRIO Comparison

Compare TCBS & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TCBS

Texas Community Bancshares Inc.

N/A

Current Price

$17.75

Market Cap

48.5M

Sector

Finance

ML Signal

N/A

Logo DarioHealth Corp.

DRIO

DarioHealth Corp.

N/A

Current Price

$6.81

Market Cap

53.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TCBS
DRIO
Founded
1934
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.5M
53.2M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
TCBS
DRIO
Price
$17.75
$6.81
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$35.00
AVG Volume (30 Days)
3.3K
12.9K
Earning Date
04-24-2026
05-14-2026
Dividend Yield
1.18%
N/A
EPS Growth
327.27
1559.02
EPS
0.31
1.25
Revenue
N/A
$7,394,000.00
Revenue This Year
N/A
$20.27
Revenue Next Year
N/A
$47.58
P/E Ratio
$57.71
$5.78
Revenue Growth
N/A
43.02
52 Week Low
$15.10
$0.38
52 Week High
$20.00
$17.74

Technical Indicators

Market Signals
Indicator
TCBS
DRIO
Relative Strength Index (RSI) 47.42 48.65
Support Level $16.02 $6.13
Resistance Level $18.33 $9.24
Average True Range (ATR) 0.30 0.58
MACD -0.04 0.09
Stochastic Oscillator 9.60 53.61

Price Performance

Historical Comparison
TCBS
DRIO

About TCBS Texas Community Bancshares Inc.

Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans, commercial real estate loans, and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer, and other.

About DRIO DarioHealth Corp.

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.

Share on Social Networks: